I

ICON plc

D
ICLR
USD
-8.905
(-3.9781%)
Market Closed
121,048.00
Volume
15.068
EPS
-
Div Yield
24.995
P/E
17,801,014,087.00
Market Cap
Today
-6.5700%
1 Week
-3.160%
1 Month
-26.039%
6 Months
-31.707%
12 Months
-16.318%
Year To Date
-24.026%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
L
LH
4.69
(2.0013%)
USD
Q
QGEN
0.92
(2.1282%)
USD
C
CRL
-12.025
(-5.4098%)
USD
P
PRAH
(%)
USD
I
IART
-1.16
(-4.3462%)
USD
T
TECH
-2.96
(-3.7261%)
USD
D
DGX
1.07
(0.6897%)
USD
I
ILMN
3.37
(2.2187%)
USD
TMO
TMO
-4.75
(-0.847%)
USD
W
WST
-5.93
(-1.8018%)
USD
P
PKI
1.92
(1.5668%)
USD

Title:
ICON plc

Sector:
Healthcare
Industry:
Diagnostics & Research
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
Do you need help or have a question?
Contact Us